Hualan Biological Engineering Inc. (SHE:002007)
China flag China · Delayed Price · Currency is CNY
12.80
-0.36 (-2.74%)
Sep 11, 2026, 3:05 PM CST

SHE:002007 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
957.4774.811,367993.771,099692.54
Short-Term Investments
1,2571,0052,1441,213240-
Trading Asset Securities
2,2752,6231,8882,1152,3692,659
Cash & Short-Term Investments
4,4894,4035,3984,3223,7083,352
Cash Growth
-13.47%-18.44%24.90%16.56%10.63%-16.72%
Accounts Receivable
1,5862,0782,0522,5902,4102,097
Other Receivables
67.596.0918.666.954.847.05
Receivables
1,6532,0842,0713,2972,7592,104
Inventory
2,7202,2892,0291,6741,4471,359
Other Current Assets
100.983.78118.4633.7163.5636.67
Total Current Assets
8,9648,8599,6169,3278,0776,851
Property, Plant & Equipment
2,9102,9822,9642,7272,2902,338
Long-Term Investments
2,0382,7843,0233,2733,6731,716
Goodwill
---1.11.11.1
Other Intangible Assets
313.6314.13319.04319.72310204.53
Long-Term Deferred Tax Assets
202.87196.85235.34241.72232.49201.25
Long-Term Deferred Charges
52.9355.3159.6959.642.4955.42
Other Long-Term Assets
65.4369.7992.74157.3116.8170.16
Total Assets
14,54815,26216,31016,10614,74311,537

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
193.34196.26217.16197.26175.49241.03
Accrued Expenses
823.78926.54914.991,1691,071947.5
Short-Term Debt
390447899.73700.35800.38800.7
Current Portion of Long-Term Debt
---300-10.18
Current Portion of Leases
0.390.390.370.360.44-
Current Income Taxes Payable
11.1818.1419.5863.369.748.71
Current Unearned Revenue
20.9510.2113.468.5714.788.28
Other Current Liabilities
290.47196.78294.83142.376.53158.53
Total Current Liabilities
1,7301,7952,3602,5812,1482,215
Long-Term Debt
----300190
Long-Term Leases
7.888.398.789.159.3-
Long-Term Unearned Revenue
72.8559.4654.1851.1854.3757.91
Long-Term Deferred Tax Liabilities
33.748.1140.1442.8220.8710.37
Total Liabilities
1,8451,8712,4632,6852,5332,473

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,8261,8271,8291,8291,8241,824
Additional Paid-In Capital
1,3811,3971,4301,4861,415105.62
Retained Earnings
7,7648,2948,6338,0937,1596,448
Treasury Stock
--17.95-32.72-48.07--40.59
Total Common Equity
10,97211,50111,85911,35910,3988,337
Minority Interest
1,7321,8901,9882,0621,812727.09
Shareholders' Equity
12,70313,39113,84713,42112,2109,064
Total Liabilities & Equity
14,54815,26216,31016,10614,74311,537

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
398.27455.78908.881,0101,1101,001
Net Cash (Debt)
4,0913,9474,4893,3122,5982,351
Net Cash Growth
-16.51%-12.07%35.54%27.50%10.51%-35.14%
Net Cash Per Share
2.242.162.461.821.421.28
Filing Date Shares Outstanding
1,8261,8271,8291,8291,8241,824
Total Common Shares Outstanding
1,8261,8271,8291,8291,8241,824
Working Capital
7,2347,0647,2566,7455,9294,636
Book Value Per Share
6.016.296.486.215.704.57
Tangible Book Value
10,65811,18611,54011,03910,0878,131
Tangible Book Value Per Share
5.846.126.316.045.534.46
Buildings
1,7731,8081,7171,3021,2061,256
Machinery
2,7142,7142,6392,5042,3832,433
Construction In Progress
658.03643.37552.48661.51216.39132.96